Iridex Licenses Laser Tech to Quantel
Laser-based medical systems provider Iridex Corp. has licensed its MicroPulse photocoagulation technology to Quantel Medical for use in clinical ophthalmic lasers.
MicroPulse is a tissue-sparing laser technology that provides ophthalmologists with a noninvasive treatment for diseases that threaten eyesight. It works by electronically “chopping” the laser emission into trains of microsecond pulses, enabling physicians to control the effects on target tissues.
“There is a significant need in the marketplace for efficient and durable therapies for retinal diseases associated with the growth of diabetes and the aging population,” said Iridex President and CEO Will Moore.
Quantel Medical of Clermont, France, is a division of Quantel that manufactures medical devices for the treatment of ocular diseases.
For more information, visit:
www.iridex.com or
www.quantel-medical.com
LATEST NEWS
- Fusion Startup Xcimer Raises $100M, Plans Laser Prototype
Jun 4, 2024
- ASML and imec Debut Joint Lithography Lab
Jun 4, 2024
- Photonic and Microsoft Detail Quantum Computing Milestone
Jun 4, 2024
- LOPS 2024 Conference to Showcase Latest Innovations
Jun 4, 2024
- Coherent Names CEO
Jun 3, 2024
- CEA-Leti Reports Progress on AI-Embedded CMOS Image Sensors
Jun 3, 2024
- Obsidian Sensors Partners, Secures Investment to Advance Thermal Image Sensor Tech
Jun 3, 2024
- Hamamatsu Completes Acquisition of NKT Photonics
May 31, 2024